BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27651903)

  • 1. Hypercalcemia associated with isolated bone marrow sarcoidosis in a patient with underlying monoclonal gammopathy of undetermined significance: case report and review of literature.
    Gubatan J; Wang X; Louissaint A; Mahindra A; Vanderpool J
    Biomark Res; 2016; 4():18. PubMed ID: 27651903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal confined sarcoidosis: Natural history and diagnostic challenge.
    Ghafoor A; Almakki A
    Avicenna J Med; 2014 Apr; 4(2):44-7. PubMed ID: 24761384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Isolated Bone Marrow Sarcoidosis Presenting as Symptomatic Hypercalcemia.
    Pietila M; Cowman BE
    S D Med; 2022 Nov; 75(11):488-490. PubMed ID: 36893024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma in association with sarcoidosis.
    Sen F; Mann KP; Medeiros LJ
    Arch Pathol Lab Med; 2002 Mar; 126(3):365-8. PubMed ID: 11860317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic stimulation of the immune system in sarcoidosis and monoclonal gammopathy of undetermined significance].
    Saad T; Agmon-Levin N; Shoenfeld Y
    Harefuah; 2009 Dec; 148(12):809-10, 857, 856. PubMed ID: 20088430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoidosis and Monoclonal Gammopathy of Undetermined Significance (MGUS): A True Association or Just a Coincidence?
    Hassanein M; Karapetyan L; Khan A; Rayamajhi S
    Case Rep Hematol; 2018; 2018():3790760. PubMed ID: 30356364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corneal deposits in monoclonal gammopathy of undetermined significance. Review of the literature and case report].
    Németh O; Tapasztó B; Tar S; Szabó V; Nagy ZZ; Tóth J; Hamed A; Mikala G; Szentmáry N
    Orv Hetil; 2018 Sep; 159(39):1575-1583. PubMed ID: 30543127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcoidosis and Multiple Myeloma: A Case Report and Literature Review.
    Tiago Serra J; Martinho A; Paixao Duarte F; Aldomiro F
    Case Rep Hematol; 2019; 2019():4586265. PubMed ID: 31781424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteolytic bone lesions, hypercalcemia and paraprotein, but not a myeloma: case report and review of literature.
    Hradská K; Jelínek T; Ďuraš J; Mihályová J; Popková T; Cvek J; Bukovanský K; Havel M; Spáčilová V; Hájek R
    Vnitr Lek; 2020; 66(5):90-95. PubMed ID: 32942878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
    Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?
    Spira D; Weisel K; Brodoefel H; Schulze M; Kaufmann S; Horger M
    Acad Radiol; 2012 Jan; 19(1):89-94. PubMed ID: 22142681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
    Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
    Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis.
    Gámez B; Edwards CM
    Curr Osteoporos Rep; 2018 Dec; 16(6):635-641. PubMed ID: 30229522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
    Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
    Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal gammopathy of undetermined significance: a new proposal of workup.
    Mangiacavalli S; Cocito F; Pochintesta L; Pascutto C; Ferretti V; Varettoni M; Zappasodi P; Pompa A; Landini B; Cazzola M; Corso A
    Eur J Haematol; 2013 Oct; 91(4):356-60. PubMed ID: 23859528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.